Connor received his Bachelor’s in Biology from the University of Dayton in 2014. Throughout his undergraduate career, Connor worked in a number of research laboratories focused on areas such as forensic/bioengineering, pathobiology, and molecular physiology.
Understanding the power that scientific research has to improve the lives of others, Connor enrolled in the Integrated Biomedical Sciences (IBMS) Program at the University of Notre Dame to earn his PhD. in Immunology and Infectious Diseases. His research interests during his PhD. program were understanding microbial pathogenesis, the host-immune response, and host-pathogen interactions. With a change in career aspirations, Connor withdrew from his PhD. program after 2 years and enrolled in the ESTEEM Program.
With a passion for rare and neglected disease research, and an extensive knowledge of advanced cell and molecular techniques and assays, Connor plans to work with large (or small) pharmaceutical companies focused on creating therapies for rare and orphan diseases. For his capstone thesis, Connor is working with Amicus Therapeutics, a global biotechnology company focused on creating advanced therapies for rare, neglected diseases. Furthermore, Connor is a Venture Intern with enFOCUS, using a problem-based approach to entrepreneurship.
After ESTEEM, Connor is interested in consulting, working with biotechnology and pharmaceutical companies, or in his own start-up. He enjoys snowboarding, sand volleyball, ice hockey, video games, and going to punk concerts.